Furthermore, whole-body knockout of ACSL3 in mice does not result in lethality or any overt dysfunction, highlighting the vulnerability of cancer cells to targeting ACSL3 [20] and prompting us to investigate whether the splicing process of pre-mACSL3 is associated with BRD4, thereby acting as a downstream effector influencing ferroptosis. This evidence concerns the gene ACSL3 and cancer.